ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img

Glutathione S-Transferase π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo

  • Zhangjian Huang*
    Zhangjian Huang
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    *Z.H.: phone, +86-25-83271072; fax, +86-25-83271072; e-mail, [email protected]
    More by Zhangjian Huang
  • Jianbing Wu
    Jianbing Wu
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    More by Jianbing Wu
  • Yu Zou
    Yu Zou
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    More by Yu Zou
  • Haoliang Yuan
    Haoliang Yuan
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    More by Haoliang Yuan
  • Yinqiu Zhang
    Yinqiu Zhang
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    More by Yinqiu Zhang
  • Yue Fei
    Yue Fei
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    More by Yue Fei
  • Atul Bhardwaj
    Atul Bhardwaj
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada
    More by Atul Bhardwaj
  • Jatinder Kaur
    Jatinder Kaur
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada
    More by Jatinder Kaur
  • Edward E. Knaus*
    Edward E. Knaus
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada
    *E.E.K.: phone, 1-780-492 5993; fax, +1-780-492 1217; e-mail, [email protected]
    More by Edward E. Knaus
  • , and 
  • Yihua Zhang*
    Yihua Zhang
    State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China
    *Y.Z.: phone, +86-25-83271015; fax, +86-25-83271015; e-mail, [email protected]
    More by Yihua Zhang
Cite this: J. Med. Chem. 2018, 61, 5, 1833–1844
Publication Date (Web):February 8, 2018
https://doi.org/10.1021/acs.jmedchem.7b01178
Copyright © 2018 American Chemical Society

    Article Views

    1591

    Altmetric

    -

    Citations

    16
    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (2)»

    Abstract

    Abstract Image

    A group of glutathione S-transferase π (GSTπ) activatable O2-(sulfonylethyl derived) diazeniumdiolates 512 were designed and synthesized. These compounds could be activated by GSTπ to initiate the β-elimination reaction, liberating an active vinyl sulfone-based GSH derivative and a diazeniumdiolate anion which subsequently releases NO in situ. The most active compound 6 released relatively high levels of NO and inhibited proliferation of melanoma B16 cells, superior to a diazeniumdiolate-based anticancer agent JS-K (1). Importantly, 6 had 8-fold less inhibitory activity against normal epithelial JB6 Cl 30-7b cells. The inhibitory activity of 6 could be diminished by an NO scavenger or GSTπ inhibitor. Furthermore, 6 induced nitration of mitochondrial tyrosine in B16 cells and inoculated B16 tumors in mice, which might be responsible for oxidation of protein leading to tumor suppression. Finally, 6 significantly retarded the B16 cells growth in a mouse xenograft model. These findings suggest that 6 may have a potential to treat melanoma.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jmedchem.7b01178.

    • HPLC, ESI-MS, and HRMS spectra for the purities of compounds 512, synthetic route and procedure of compound 15, peak shift after cell is stained with DAF-FM DA analyzed by FACS, and effects of 6 on mice body weights and survival curves of each tested group in vivo (PDF)

    • Molecular formula strings for compounds 512 (CSV)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 16 publications.

    1. Hui Ye, Jianbing Wu, Zhuangzhuang Liang, Yihua Zhang, Zhangjian Huang. Protein S-Nitrosation: Biochemistry, Identification, Molecular Mechanisms, and Therapeutic Applications. Journal of Medicinal Chemistry 2022, 65 (8) , 5902-5925. https://doi.org/10.1021/acs.jmedchem.1c02194
    2. Tao Sun, Tian Lv, Jianbing Wu, Mingchao Zhu, Yue Fei, Jie Zhu, Yihua Zhang, Zhangjian Huang. General Strategy for Integrated Bioorthogonal Prodrugs: Pt(II)-Triggered Depropargylation Enables Controllable Drug Activation In Vivo. Journal of Medicinal Chemistry 2020, 63 (22) , 13899-13912. https://doi.org/10.1021/acs.jmedchem.0c01435
    3. Wei Liu, Yu Zhang, Jiaming He, Yue Yu, Jiajun Yuan, Xiaoyi Ye, Ziwu Zhang, Liang Xue, Hua Cao. Transition-Metal-Free Three-Component Reaction: Additive Controlled Synthesis of Sulfonylated Imidazoles. The Journal of Organic Chemistry 2019, 84 (17) , 11348-11358. https://doi.org/10.1021/acs.joc.9b01818
    4. Pejman Ghaffari‐Bohlouli, Hafez Jafari, Oseweuba Valentine Okoro, Houman Alimoradi, Lei Nie, Guohua Jiang, Ashok Kakkar, Amin Shavandi. Gas Therapy: Generating, Delivery, and Biomedical Applications. Small Methods 2024, 1 https://doi.org/10.1002/smtd.202301349
    5. Shixin Liu, Guowei Li, Dong Ma. Controllable Nitric Oxide‐Delivering Platforms for Biomedical Applications. Advanced Therapeutics 2022, 5 (3) https://doi.org/10.1002/adtp.202100227
    6. Xiujie Zhou, Niuniu Zhang, Yuzhen Li, Zuyu Mo, Xianli Ma, Yanyan Chen, Yanli Xu. Metal-free synthesis of 3-sulfonyl-5-selanyl-4a,8a-dihydro-2H-chromen-6(5H)-ones via visible light driven intermolecular cascade cyclization of alkyne-tethered cyclohexadienones and selenosulfonates. Green Synthesis and Catalysis 2021, 2 (4) , 397-400. https://doi.org/10.1016/j.gresc.2021.07.004
    7. Jianbing Wu, Tao Sun, Chenxi Yang, Tian Lv, Yuyang Bi, Yuan Xu, Yong Ling, Jun Zhao, Rigang Cong, Yihua Zhang, Jianhua Wang, Hao Wen, Hulin Jiang, Fei Li, Zhangjian Huang. Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide in vivo. Biomaterials Science 2021, 9 (5) , 1816-1825. https://doi.org/10.1039/D0BM01841D
    8. Yueqi Yang, Zhangjian Huang, Li-Li Li. Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications. Nanoscale 2021, 13 (2) , 444-459. https://doi.org/10.1039/D0NR07484E
    9. Jintong Du, Jing Guo, Dongwei Kang, Zhihong Li, Guan Wang, Jianbing Wu, Zhen Zhang, Hao Fang, Xuben Hou, Zhangjian Huang, Guobo Li, Xiaoyun Lu, Xinyong Liu, Liang Ouyang, Li Rao, Peng Zhan, Xiaojin Zhang, Yihua Zhang. New techniques and strategies in drug discovery. Chinese Chemical Letters 2020, 31 (7) , 1695-1708. https://doi.org/10.1016/j.cclet.2020.03.028
    10. Sabrina Dallavalle, Vladimir Dobričić, Loretta Lazzarato, Elena Gazzano, Miguel Machuqueiro, Ilza Pajeva, Ivanka Tsakovska, Nace Zidar, Roberta Fruttero. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resistance Updates 2020, 50 , 100682. https://doi.org/10.1016/j.drup.2020.100682
    11. Prabaharan Thiruvengetam, Rajan Deepan Chakravarthy, Dillip Kumar Chand. A molybdenum based metallomicellar catalyst for controlled and chemoselective oxidation of activated alcohols in aqueous medium. Journal of Catalysis 2019, 376 , 123-133. https://doi.org/10.1016/j.jcat.2019.06.013
    12. Fumou Sun, Yang Wang, Xiaojun Luo, Zhaoxiong Ma, Yao Xu, Xinrong Zhang, Tian Lv, Yihua Zhang, Min Wang, Zhangjian Huang, Juan Zhang. Anti-CD24 Antibody–Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. Cancer Research 2019, 79 (13) , 3395-3405. https://doi.org/10.1158/0008-5472.CAN-18-2839
    13. Hiroshi Tsugawa, Ryo Nakabayashi, Tetsuya Mori, Yutaka Yamada, Mikiko Takahashi, Amit Rai, Ryosuke Sugiyama, Hiroyuki Yamamoto, Taiki Nakaya, Mami Yamazaki, Rik Kooke, Johanna A. Bac-Molenaar, Nihal Oztolan-Erol, Joost J. B. Keurentjes, Masanori Arita, Kazuki Saito. A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms. Nature Methods 2019, 16 (4) , 295-298. https://doi.org/10.1038/s41592-019-0358-2
    14. Lu Lu, Xuemin Rao, Rigang Cong, Chenxi Zhang, Zhimei Wang, Jinyi Xu, Genzoh Tanabe, Osamu Muraoka, Xiaoming Wu, Weijia Xie. Design, Synthesis and Biological Evaluation of Nitrate Derivatives of Sauropunol A and B as Potent Vasodilatory Agents. Molecules 2019, 24 (3) , 583. https://doi.org/10.3390/molecules24030583
    15. Keith S. Wong, Walid A. Houry. Recent Advances in Targeting Human Mitochondrial AAA+ Proteases to Develop Novel Cancer Therapeutics. 2019, 119-142. https://doi.org/10.1007/978-981-13-8367-0_8
    16. Na Li, Manyi Xu, Na Bao, Wei Shi, Qixing Li, Xiaowei Zhang, Jianbo Sun, Li Chen. Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities. European Journal of Medicinal Chemistry 2018, 160 , 1-8. https://doi.org/10.1016/j.ejmech.2018.10.013

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect